AstraZeneca appoints Ram Mudaliar as India Lead of its Clinical Data and Insights division

AstraZeneca India yesterday announced the appointment of Ram Mudaliar as the India lead of their Clinical Data and Insights (CDI) division. Prior to his appointment as the CDI India Lead, Mudaliar worked with AstraZeneca Canada, managing delivery of the lung portfolio and leading oncology data management teams in the north-American region and in Europe. He has also worked as Interim Global Head of oncology in data management for a brief period, a statement from AstraZeneca said.

The statement also said that the CDI division in Bengaluru is a critical advancement to support a growing global portfolio and build on internal data expertise. Mudaliar’s appointment follows the launch of the CDI India division in October 2021.

As CDI India Lead, he will be responsible for establishing and expanding the CDI footprint in India, liaising with CDI global and local leaders to develop and implement strategic decisions for the India site. He is also responsible for ensuring the local planning and coordination relating to facilities and enabling support for the India team, connecting with facilities management, human resources, IT, compliance, R&D site leadership and other functions, as required.

On his appointment, Ram Mudaliar, CDI India Lead, AstraZeneca, said, “The way in which we manage data is evolving, and the CDI division in India will prepare AstraZeneca for managing clinical data at exponential volume, scale and complexity. The team will support translating the huge volume of clinical information into meaningful insights for the organisation, further strengthening our ability to solve complex business problems and serve patients with an innvovative data-driven approach…..”